Womens Health Diagnostics Market Research Report 2027 Industry Major Strategies Adopted By Companies

According to the new market research report "Women's Health Diagnostics Market by Application (Biopsy, Cervical & Ovarian Cancer Testing, PAP Smear, HPV, TORCH, Prenatal Testing, Hepatitis, Ultrasound, Obstetrics), End User (Hospitals, Clinics, Home Care), COVID-19 Impact – Global Forecast to 2025", published by MarketsandMarkets™, the global Women's Health Diagnostics Market is projected to reach USD 36.6 billion by 2025 from USD 25.0 billion in 2020, at a CAGR of 7.9% during the forecast period. In the past decade, the demand for various health diagnostic tests has increased significantly across the globe.

The growing prevalence of chronic diseases such as breast cancer, uterine cancer, and cervical cancer, among others, is one of the major drivers of the global women’s health diagnostics market. According to the WHO, breast cancer is the most common cancer among women, accounting for 25% of all cancer cases and 15% of all cancer deaths in women. The increasing prevalence of chronic diseases is resulting in an increasing demand for effective and early diagnosis of these diseases, which is driving the growth of the market.

In addition, the rising demand for personalized healthcare and the technological advancements in diagnostics methods such as next-generation sequencing, digital PCR, and mass spectrometry are some of the other drivers of the market.

Get a sample of the report: https://www.prnewswire.com/news-releases/womens-health-diagnostics-market-worth-36-6-billion-by-2025--exclusive-report-by-marketsandmarkets-301224820.html

Top Lading Players: Quest Diagnostics Incorporated (US), Hologic, Inc. (US), Siemens AG (Germany), PerkinElmer, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Cardinal Health, Inc. (US), General Electric Company (US), Becton, Dickinson and Company (US), Abbott Laboratories (US), bioMérieux SA (France), Koninklijke Philips N.V. (Netherlands), Guided Therapeutics, Inc. (US), SuperSonic Imagine (France), FUJIFILM Holdings Corporation (Japan), DIALAB GmbH (Austria), Carestream Health, Inc. (US), MedGyn Products, Inc. (US), Cook Medical, Inc. (US), Osteometer MediTech, Inc. (Denmark), and NeuroLogica Corporation (US)

Some Key Highlights from the Report:

1. The global women’s health diagnostics market is estimated to reach USD 36.6 billion in 2025, registering a CAGR of 7.9% during the forecast period (2020–2025).

2. The market is primarily driven by the increasing prevalence of gynecological disorders and the rising awareness about preventive healthcare.

3. In addition, the increasing number of women opting for early diagnosis and the rising demand for non-invasive diagnostics are also driving the growth of the market.

4. The rising prevalence of reproductive disorders, such as infertility and PCOS, is also expected to fuel the growth of the market.

5. Growing technological advancements in the diagnostics sector and the rising demand for personalized healthcare are expected to further propel the growth of the market.

6. On the basis of product, the market is segmented into imaging systems, laboratory instruments, reagents, and consumables.

7. Imaging systems segment held the largest share of the market in 2019, owing to the increasing demand for non-invasive diagnostic tests and the growing prevalence of gynecological disorders.

8. The laboratory instruments segment is expected to register the highest CAGR during the forecast period, owing to the growing demand for more accurate and cost-effective tests.

9. On the basis of application, the market is segmented into infertility, oncology, endometriosis, and other applications.

10. The infertility segment held the largest share of the market in 2019, owing to the rising prevalence of infertility and the increasing awareness about infertility treatments.

Segments covered in the report:

By Application

• Osteoporosis Testing
• OVC Testing
• Cervical Cancer Testing
• Breast Cancer Testing
• Pregnancy & Fertility Testing
• Prenatal Genetic Screening & Carrier Testing
• Infectious Disease Testing
• STD Testing
• Ultrasound Tests

By End User

• Hospitals & Clinics
• Diagnostic and Imaging Centers
• Home Care Settings

Ask for Customize Research Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=128928901

Regional Outlook:

• North America (U.S.A., Canada, Mexico)
• Europe (Italy, U.K., Germany, France, Rest of Europe)
• Asia Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
• Latin America (Chile, Brazil, Argentina, Peru, Rest of Latin America)
• Middle East Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Key Questions Addressed in the Report:

1.What are the dominating factors that are influencing the growth of the industry?

2.In the forecast period, which market segment is expected to rise the most?

3.What are the risks and challenges that the industry is facing?

4.In the coming years, which area is projected to dominate the market?

5.Who are the major players in the market?

6.What kind of strategic business plans have they made?

Get More Insights @ https://www.digitaljournal.com/pr/news/womens-health-diagnostics-market-worth-36-6-billion-by-2025-projected-growth-and-opportunities-finds-marketsandmarkets-

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Aashish Mehra

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: +1-888-600-6441

Email: sales@marketsandmarkets.com

Article source: https://article-realm.com/article/Health-Fitness/Exercise/41282-Womens-Health-Diagnostics-Market-Research-Report-2027-Industry-Major-Strategies-Adopted-By-Companies.html